Patents by Inventor Hifumi Ohishi

Hifumi Ohishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10610537
    Abstract: The present invention provides a method of producing a sialooligosaccharide, which comprises: (1) hydrolyzing a sialoglycoprotein by heating at a temperature from 70 to 90° C. in an alkaline aqueous solution; and (2) purifying the hydrolysate to obtain the sialooligosaccharide, wherein a weight ratio of sialic acid to hexose contained in the resulting sialooligosaccharide is from 0.5 to 0.9.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: April 7, 2020
    Assignee: MASAYOSHI LTD.
    Inventors: Hifumi Ohishi, Rie Tokuyama, Haruka Arao, Changfang Zhou, Hisanori Tani, Takashi Hattori
  • Publication number: 20180055863
    Abstract: The present invention provides a method of producing a sialooligosaccharide, which comprises: (1) hydrolyzing a sialoglycoprotein by heating at a temperature from 70 to 90° C. in an alkaline aqueous solution; and (2) purifying the hydrolysate to obtain the sialooligosaccharide, wherein a weight ratio of sialic acid to hexose contained in the resulting sialooligosaccharide is from 0.5 to 0.9.
    Type: Application
    Filed: August 23, 2017
    Publication date: March 1, 2018
    Inventors: Hifumi OHISHI, Rie TOKUYAMA, Haruka ARAO, Changfang ZHOU, Hisanori TANI, Takashi HATTORI
  • Patent number: 8425949
    Abstract: The present disclosure provides an external use composition for skin comprising a tarajo holly leaf extract and a Japanese knotweed leaf extract, a brown algae extract and an egg shell membrane derived peptide (ESM-P) having a molecular mass of 3 kDa or higher. The composition according to the present invention can be used to treat a disease or condition of skin relating to a filaggrin metabolism anomaly, such as atopic dermatitis. The composition according to the present invention can be used specifically for the therapy of atopic dermatitis.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: April 23, 2013
    Assignee: Hydrox, Inc.
    Inventors: Hifumi Ohishi, Keizou Ohishi, Tetsuya Oishi, Hisanori Tani
  • Publication number: 20120114690
    Abstract: The present disclosure provides an external use composition for skin comprising a tarajo holly leaf extract and a Japanese knotweed leaf extract, a brown algae extract and an egg shell membrane derived peptide (ESM-P) having a molecular mass of 3 kDa or higher. The composition according to the present invention can be used to treat a disease or condition of skin relating to a filaggrin metabolism anomaly, such as atopic dermatitis. The composition according to the present invention can be used specifically for the therapy of atopic dermatitis.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 10, 2012
    Inventors: Hifumi OHISHI, Keizou Ohishi, Tetsuya Oishi, Hisanori Tani
  • Publication number: 20070178181
    Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
    Type: Application
    Filed: October 26, 2006
    Publication date: August 2, 2007
    Inventors: Claude Jensen, Afa Palu, Hifumi Ohishi, Hisanori Tani
  • Patent number: 7186422
    Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: March 6, 2007
    Assignee: Morinda, Inc.
    Inventors: Claude Jarakae Jensen, Afa Kehaati Palu, Hifumi Ohishi, Hisanori Tani
  • Publication number: 20050147700
    Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
    Type: Application
    Filed: November 19, 2004
    Publication date: July 7, 2005
    Inventors: Claude Jensen, Afa Palu, Hifumi Ohishi, Hisanori Tani
  • Patent number: 6855345
    Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: February 15, 2005
    Assignee: Morinda, Inc.
    Inventors: Claude Jarakae Jensen, Afa Kehaati Palu, Hifumi Ohishi, Hisanori Tani
  • Publication number: 20030138506
    Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
    Type: Application
    Filed: November 1, 2002
    Publication date: July 24, 2003
    Inventors: Claude Jarakae Jensen, Afa Kehaati Palu, Hifumi Ohishi, Hisanori Tani